doi: 10.1016/s0733-8635(02)00026-8
Ipamorelin (no DAC), a selective ghrelin receptor (GHS-R1a) agonist, induces GH release through calcium-dependent mechanisms without affecting prolactin or cortisol, offering a clean, receptor-specific action profile
In a clinical or home setting (with proper guidance), it is often injected in areas such as the upper arm, thigh, hip, or buttock
According to the FDA-approved prescribing information, gastrointestinal adverse reactions (nausea, vomiting, diarrhea) occur in up to 43% of patients taking Mounjaro and 37% of patients taking Zepbound, with higher rates during dose escalation phases
11,180182 GIP is secreted by K cells in the small intestine
The great controversy of obstructive sleep apnea treatment for cardiovascular risk benefit: advancing the science through expert consensus